建元信托股份有限公司诉讼进展公告

Core Viewpoint - The announcement details the litigation progress of Jianyuan Trust Co., Ltd., including settlements and arbitration outcomes, which may impact the company's financials. Group 1: Litigation Status - One case has been settled and withdrawn, one arbitration ruling has been revoked, and one case has been withdrawn [2] - The company is a defendant in the settled and withdrawn cases, while it is the applicant in the revoked arbitration case [2] Group 2: Financial Implications - The settled case involved a litigation amount of 177.87 million yuan, the revoked arbitration case involved a principal amount of 10 million yuan, and the withdrawn case involved 365,600 yuan [2] - The company will recognize liabilities based on the settlement results for the settled case, and will reverse previously recognized liabilities for the revoked arbitration case [2][7] Group 3: Specific Case Details - In the case involving Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd., a settlement agreement was signed on August 13, 2025, with the company paying 56.99 million yuan [3][4] - The company received a civil ruling allowing the withdrawal of the case, with the litigation costs borne by Changzhou Qianhong [4] Group 4: Other Litigation Developments - In the case involving Haoke Technology Co., Ltd., the company was ordered to return a trust principal of 10 million yuan, but the arbitration ruling was later revoked by the Shanghai Financial Court [5][6] - A separate case involving a natural person had its claim amount adjusted from 1.6 million yuan to 365,600 yuan [7]